PDT Partners’s Medifast MED Stock Holding History

PDT Partners’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$313K	Buy	+30,723	New	+$331K	0.02%	462
2021 Q4	–	Sell	-3,000	Closed	-$578K	–	955
2021 Q3	$578K	Sell	3,000 -900	-23%	-$221K	0.04%	441
2021 Q2	$1.1M	Buy	+3,900	New	+$1.06M	0.07%	364
2016 Q4	–	Sell	-13,810	Closed	-$522K	–	537
2016 Q3	$522K	Buy	13,810 +200	+1%	+$7.17K	0.03%	369
2016 Q2	$453K	Hold	13,610	–	–	0.04%	337
2016 Q1	$411K	Buy	13,610 +3,900	+40%	+$114K	0.03%	435
2015 Q4	$295K	Sell	9,710 -32,641	-77%	-$972K	0.04%	318
2015 Q3	$1.14M	Sell	42,351 -17,683	-29%	-$515K	0.03%	677
2015 Q2	$1.94M	Buy	60,034 +38,634	+181%	+$1.23M	0.05%	441
2015 Q1	$641K	Buy	21,400 +4,200	+24%	+$133K	0.02%	929
2014 Q4	$577K	Buy	17,200 +5,441	+46%	+$169K	0.05%	429
2014 Q3	$386K	Sell	11,759 -3,527	-23%	-$108K	0.01%	1027
2014 Q2	$465K	Sell	15,286 -5,655	-27%	-$176K	0.01%	1046
2014 Q1	$609K	Buy	+20,941	New	+$561K	0.01%	849

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

PDT Partners's MED Position: Q1 2026 in Review

PDT Partners opened a new position in Medifast (MED) in Q1 2026: 30,723 shares worth $313K. The stake represents 0.02% of the portfolio and ranks #462 among its holdings. This is a return to the name: PDT Partners previously reported a position in MED as recently as Q3 2021.

PDT Partners first reported a position in MED in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.94M in Q2 2015. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

PDT Partners held 30,723 shares of Medifast worth $313K as of Q1 2026.
Medifast was a new PDT Partners position in Q1 2026.
Medifast made up 0.02% of PDT Partners's portfolio in Q1 2026, its #462 holding.
PDT Partners first reported a position in Medifast in Q1 2014 and has held it in 14 quarters since.
PDT Partners's Medifast position peaked at $1.94M in Q2 2015.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.